Lotilaner

Lotilaner (CAS 1398609-39-6) is a systemic isoxazoline ectoparasiticide developed for veterinary use, primarily in dogs and cats. It acts by inhibiting GABA- and glutamate-gated chloride channels, leading to rapid paralysis and death of fleas and ticks. This compound is characterized by its high potency and prolonged duration of action, making it a preferred choice in oral formulations for ectoparasite control.

We supply Lotilaner as a white to off-white powder with a purity of ≥98% (HPLC), suitable for pharmaceutical formulation and veterinary product development. Each batch is accompanied by a COA, MSDS, and TDS, ensuring traceability and compliance with regulatory standards.

Synonymes : Lotilaner, 4-[(5RS)-5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-N-[(4-methoxyphenyl)methyl]-2-methylbenzamide

Applications

• Veterinary oral solutions for flea and tick control in dogs and cats
• Combination products with other antiparasitic agents
• R&D for novel ectoparasiticide formulations

Quality & Documentation

Every batch is tested for assay (HPLC ≥98%), loss on drying (≤0.5%), and heavy metals (≤10 ppm). Full COA, MSDS, and TDS are available on request. Stability data can be provided to support your qualification and registration processes.

Packaging & Supply

Standard packaging: 1 kg, 5 kg, and 25 kg; bulk and custom packing available. In-stock items ship within 3-5 days; MOQ from 1 kg. For pricing, samples, and bulk orders, contact our sales team.

Demande de devis

• Notre adresse: 280, rue Main, Xi'an, Shaanxi, Chine
• LyvBio Co. — E-mail : info@lyvbio.com